Alzheimer’s disease is a debilitating neurodegenerative disease and the most common form of dementia. Symptoms include irritability, confusion, mood swings, language difficulties and memory loss. Cognitive dysfunction becomes more pronounced as the disease progresses, leading to the loss of bodily functions and eventually death.
Alzheimer’s disease is characterized by the presence of amyloid plaques in the brain. Soluble beta-amyloid (Abeta) oligomers are thought to underlie the cognitive deficits associated with Alzheimer’s disease. Cognition Therapeutics therapies pharmacologically compete with Abeta oligomers for critical receptor targets preventing synapse loss and improving memory and their small molecule therapeutics act through molecular targets that have not been previously implicated in Alzheimer’s disease.
Cognition Therapeutics has received a US patent that describes the discovery of several candidate drug molecules which can stop the effects of the brain protein that appears to play a major role in development of Alzheimer's disease. Disease-relevant screening technologyclosely models the pathology of neurodegenerative diseases and novel, high-quality CNS-biased chemical libraries. These platforms can predict behavioral efficacy of candidate drugs in Alzheimer's models. U.S. National Stage Application: No. 13/263,162, entitled "Inhibitors of Cognitive Decline" was filed on October 6, 2011.
CogRx CEO Hank Safferstein said, "The allowance of this patent demonstrates the strength of Cognition Therapeutics's intellectual property and high-level recognition that its technologies are both relevant and of great value to the therapy and ultimate conquering of Alzheimer's disease."
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- A Vegetarian Carnivorous Plant...Wait, What?
- Parkinson’s Disease Reverted In Rats
- Wave-Particle Duality' And Quantum Uncertainty - Two Sides Of The Same Mystery?
- Mental Illnesses Run In Families, So How Can We Protect Children?
- Guest Post: Ben Allanach, On Open Access
- Dr. Ozvorkian And The Amoebas
- Only One Third Of Dr. Oz Show Recommendations Is Believable, Finds Analysis
- "Just like the Marxist loving drunken addicted thugs who chase conservatives off stage that you..."
- "I wonder how ordinary MDs and specialists would do if subjected to the same level scrutiny? Probably..."
- "Given that I see my doctor whenever I am ill and I trust my doctor's judgment in all except the..."
- "This is a much better summary of the study than a lot of the articles out there. People make..."
- "Every theoretical astrophysicist disagrees with you. No they don't. Most agree that black holes..."